Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peiyuan capsule
- Development stage
- Phase 1
- Lead developer
- Anhui Province Chinese Medicine Hospital
- Administration
- Oral
01
Overview
Peiyuan capsule (also known as Bushen Peiyuan capsule) is a traditional Chinese medicine (TCM) herbal formulation developed by the Anhui Province Chinese Medicine Hospital (First Affiliated Hospital of Anhui University of Chinese Medicine). It is formulated to treat stable chronic obstructive pulmonary disease (COPD) in patients presenting with a TCM syndrome pattern of lung-kidney qi deficiency with phlegm and blood stasis obstructing the lung. The therapeutic effects of the capsule are evaluated in clinical trials assessing lung function, frequency and severity of acute COPD exacerbations, dyspnea, exercise capacity, and overall quality of life.
- Other names
- Bushen Peiyuan capsule培元胶囊补肾培元胶囊
Beyond the preview
Go deeper on Peiyuan capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peiyuan capsule.